BRPI1013716A2 - 5-alquinil-piridinas. - Google Patents

5-alquinil-piridinas.

Info

Publication number
BRPI1013716A2
BRPI1013716A2 BRPI1013716A BRPI1013716A BRPI1013716A2 BR PI1013716 A2 BRPI1013716 A2 BR PI1013716A2 BR PI1013716 A BRPI1013716 A BR PI1013716A BR PI1013716 A BRPI1013716 A BR PI1013716A BR PI1013716 A2 BRPI1013716 A2 BR PI1013716A2
Authority
BR
Brazil
Prior art keywords
pyridines
alkynyl
alkynyl pyridines
Prior art date
Application number
BRPI1013716A
Other languages
English (en)
Inventor
Lars Van Der Veen
Siegfried Schneider
Tobias Wunberg
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40719954&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1013716(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI1013716A2 publication Critical patent/BRPI1013716A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI1013716A 2009-04-21 2010-04-21 5-alquinil-piridinas. BRPI1013716A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09158327 2009-04-21
PCT/EP2010/055293 WO2010122069A1 (en) 2009-04-21 2010-04-21 5-alkynyl-pyridines

Publications (1)

Publication Number Publication Date
BRPI1013716A2 true BRPI1013716A2 (pt) 2016-04-05

Family

ID=40719954

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013716A BRPI1013716A2 (pt) 2009-04-21 2010-04-21 5-alquinil-piridinas.

Country Status (23)

Country Link
US (2) US20110098275A1 (pt)
EP (1) EP2421846B1 (pt)
JP (1) JP5635592B2 (pt)
KR (1) KR20120004529A (pt)
CN (1) CN102459224A (pt)
AP (1) AP2011005894A0 (pt)
AR (1) AR076332A1 (pt)
AU (1) AU2010240963A1 (pt)
BR (1) BRPI1013716A2 (pt)
CA (1) CA2759368A1 (pt)
CL (1) CL2011002625A1 (pt)
CO (1) CO6460762A2 (pt)
EA (1) EA201101517A1 (pt)
EC (1) ECSP11011454A (pt)
IL (1) IL215161A0 (pt)
MA (1) MA33222B1 (pt)
MX (1) MX2011011021A (pt)
PE (1) PE20120637A1 (pt)
SG (1) SG175272A1 (pt)
TN (1) TN2011000531A1 (pt)
TW (1) TW201103905A (pt)
UY (1) UY32565A (pt)
WO (1) WO2010122069A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2551085T3 (es) 2009-03-23 2015-11-16 Glenmark Pharmaceuticals S.A. Proceso para preparar derivados de pirimidina-diona condensados, útiles como moduladores de TRPA1
PT2411395E (pt) 2009-03-23 2013-06-06 Glenmark Pharmaceuticals Sa Derivados de furopirimidinadiona como moduladores de trpa1
US8466162B2 (en) * 2011-01-26 2013-06-18 Boehringer Ingelheim International Gmbh 5-alkynyl-pyridines
WO2013177092A1 (en) * 2012-05-23 2013-11-28 Sunshine Lake Pharma Co., Ltd. Substituted alkynyl pyridine compounds and methods of use
ES2838573T3 (es) 2014-08-21 2021-07-02 Bristol Myers Squibb Co Derivados de benzamida ligados como inhibidores potentes de ROCK
US11001559B2 (en) 2016-08-15 2021-05-11 Purdue Research Foundation 4-substituted aminoisoquinoline derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
ES2359836T3 (es) * 2004-04-23 2011-05-27 Bristol-Myers Squibb Company Heterociclos monociclicos como inhibidores de quinasa.
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
EP1863805A1 (en) 2005-02-01 2007-12-12 AstraZeneca AB Pyrimidine compounds having tie2 (tek) inhibitory activity
EP2099757B1 (en) 2006-11-16 2014-06-25 Allergan, Inc. Sulfoximines as kinase inhibitors
NZ590558A (en) 2008-07-29 2012-12-21 Boehringer Ingelheim Int 5-alkynyl-pyrimidines
EP2327704A4 (en) * 2008-08-29 2012-05-09 Shionogi & Co RING-CONDENSED AZOL DERIVATIVE WITH PI3K-INHIBITING EFFECT

Also Published As

Publication number Publication date
WO2010122069A1 (en) 2010-10-28
UY32565A (es) 2010-11-30
MA33222B1 (fr) 2012-04-02
AU2010240963A1 (en) 2011-10-13
CA2759368A1 (en) 2010-10-28
US9090564B2 (en) 2015-07-28
CN102459224A (zh) 2012-05-16
US20110098275A1 (en) 2011-04-28
MX2011011021A (es) 2011-11-02
TW201103905A (en) 2011-02-01
SG175272A1 (en) 2011-11-28
AR076332A1 (es) 2011-06-01
AP2011005894A0 (en) 2011-10-31
TN2011000531A1 (en) 2013-05-24
IL215161A0 (en) 2011-12-29
KR20120004529A (ko) 2012-01-12
JP2012524750A (ja) 2012-10-18
CL2011002625A1 (es) 2012-04-20
EA201101517A1 (ru) 2012-05-30
EP2421846B1 (en) 2016-01-06
EP2421846A1 (en) 2012-02-29
ECSP11011454A (es) 2011-12-30
JP5635592B2 (ja) 2014-12-03
US20130196975A1 (en) 2013-08-01
CO6460762A2 (es) 2012-06-15
PE20120637A1 (es) 2012-05-26

Similar Documents

Publication Publication Date Title
BR112012000763A2 (pt) derivados de piridin-4-ila
BRPI1012883A2 (pt) dispositivo intercorporal.
BRPI1008774A2 (pt) espiroamida substituída
BRPI1016117A2 (pt) derivados de isoxazol-isoxazol e isoxasol-isotiazol.
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
AT507924A3 (de) Gleitelement
BRPI1015139A2 (pt) Bebida instantânea
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BR112012004964A2 (pt) girocóptero
BRPI1008070A2 (pt) tricianoboratos
BR112012005960A2 (pt) n-fenil-1-(4-piridinil)-1h-pirazol-3-aminas substituídas
DK2442870T3 (da) Pyrazinooxazepin-derivater.
IT1396487B1 (it) Convogliatore.
BRPI1016192A2 (pt) derivados de soxazol.
DK2373644T3 (da) Pyridazinonderivater
IT1396315B1 (it) Dispositivo modulare appendiabiti.
BRPI1010159A2 (pt) bistuti
BRPI1013716A2 (pt) 5-alquinil-piridinas.
BR112012014459A2 (pt) derivados de pirrolidina.
ES1070429Y (es) Traspaleta mejorada
FR2942385B1 (fr) Grille-pain.
BR112012003616A2 (pt) metilpirroloprimidinacarboxamidas
IT1394461B1 (it) Dispositivo spollonatore.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]